Godwin Ofikwu
Colon & Rectal Surgery · Henderson, NVNPI 1396056404
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (39.4%), food and beverage and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Intuitive Surgical at 53.1% of the total. Reporting peaked in 2019 at $2,584 and has fallen 50.9% since, to $1,268 in 2025.
Across 39 payments — averaging $120.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- Medtronic$1K
- Boston Scientific$310
- Aroa Biosurgery Incorporated$172
- Mallinckrodt Hospital Products Inc.$117
- Merck$102
- plus $427 from 8 others
What the payments were for
- Travel & lodging$1,85839%
- Food & beverage$1,77138%
- Education$1,00021%
- Gifts$822%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 15 | $2,500 |
| Medtronic | 10 | $1,083 |
| Boston Scientific | 2 | $310 |
| Aroa Biosurgery Incorporated | 1 | $172 |
| Mallinckrodt Hospital Products Inc. | 1 | $117 |
| Merck | 1 | $102 |
| Olympus Corporation Of The Americas | 1 | $101 |
| Activ Surgical, Inc. | 1 | $86 |
| Braintree Laboratories, Inc. | 1 | $82 |
| Davol Inc. | 2 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Sun Pharmaceutical Industries Inc. | 1 | $22 |
| Olympus America Inc. | 1 | $21 |
| Organogenesis Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few colon & rectal surgery providers in Nevadato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naloxone Hcl | 11 | $609 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 35 | $528 |
| Neomycin Sulfate | 27 | $142 |
| Lactulose | 19 | $117 |
| Metronidazole | 30 | $103 |
| Oxycodone Hcl | 12 | $47 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Henderson
- Adan Castrodad-CaraballoHenderson$3K
- Garrett FriedmanLas Vegas$1.2M
- Roger HsiungLas Vegas$44K
- Kent SasseReno$44K
- Leslie BrowderNorth Las Vegas$10K
- Ren Yu ZhangLas Vegas$8K
- Ketan ThankiLas Vegas$7K
- Anathea PowellReno$6K
- Calvin LyonsLas Vegas$6K
- Melissa MilesLas Vegas$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.